Studies related to Exercise Capacity in COPD and L-Carnitine

L-carnitine As An Ergogenic Aid For Patients With Chronic Obstructive Pulmonary Disease Submitted To Whole-body And Respiratory Muscle Training Programs

Effect Increase
Trial Design Randomized trial
Trial Length 1-6 months
Number of Subjects 16
Sex Both Genders
Age Range 45-64, 65+
Notes for this study:
This study randomly assigned 16 individuals with moderate to severe chronic obstructive pulmonary disease (COPD) to 1g of l-carnitine or placebo, twice daily, alongside a one hour training program consisting of 30 minutes of walking on a treadmill and inspiratory muscle training, three times weekly for six weeks.